PARIS — Eric D. Donnenfeld, MD, speaks about ALG-1007 (Allegro Ophthalmics), a new integrin regulator that inhibits the complement cascade of inflammation in dry eye disease. The initial proof-of-concept first-in-human study shows promise.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.